Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy

Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System

(2014) Nina T. Grossman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia

(2012) Dhara N. Shah et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China

(2012) C. Jiang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Susceptibilities of Yeast Species to Fluconazole and Voriconazole as Determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study

(2012) H. Wang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

(2011) Michael A. Pfaller   AMERICAN JOURNAL OF MEDICINE

Transcriptional Profiling of Azole-Resistant Candida parapsilosis Strains

(2011) A. P. Silva et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Polymorphic Microsatellite Markers Able To Distinguish among Candida parapsilosis Sensu Stricto Isolates

(2010) R. Sabino et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility

(2009) Eveline C. van Asbeck et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers source

(2009) Rigoberto Hernández-Castro et al.   EUROPEAN JOURNAL OF PEDIATRICS

Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis Strains

(2008) S. Schubert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

(2008) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida parapsilosis, an Emerging Fungal Pathogen

(2008) D. Trofa et al.   CLINICAL MICROBIOLOGY REVIEWS

Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and Micafungin

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mutations in the multi-drug resistance regulatorMRR1, followed by loss of heterozygosity, are the main cause ofMDR1overexpression in fluconazole-resistantCandida albicansstrains

(2008) Nico Dunkel et al.   MOLECULAR MICROBIOLOGY